CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
Clinical trials for CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart failure drug puzzle: study aims to untangle polypharmacy risks
Knowledge-focused OngoingThis study tracks 130 people with chronic heart failure to understand how taking multiple medications (polypharmacy) affects their safety, adherence, and health outcomes. Researchers will look for patterns of over- or under-prescribing and factors linked to low medication adheren…
Matched conditions: CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
Sponsor: National Medical Research Center for Therapy and Preventive Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Real-World data on vericiguat for heart failure in india
Knowledge-focused OngoingThis study looks at medical records from over 600 Indian adults with chronic heart failure who were prescribed vericiguat between 2022 and 2023. Researchers want to see how the drug is used in routine care, how well it works, and what side effects occur. No new tests or visits ar…
Matched conditions: CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC